Paul J. Schmitt
Director/Board Member presso Gel Med Sciences, Inc.
Profilo
Mr. Paul J.
Schmitt is a Member-Managers Board at JBS United Animal Health II LLC, a Member-Managers Board at Penn State Research Foundation and a Partner at Novitas Capital III LP.
He is on the Board of Directors at Cernostics, Inc., Bellrock Intelligence, Inc., Gel Med Sciences, Inc. and The Wistar Institute.
Mr. Schmitt was previously employed as a Chief Executive Officer by Amorcyte, Inc., an Independent Director by TetraLogic Pharmaceuticals Corp., a Managing Director by Novitas Capital, a Chairman, President & Chief Executive Officer by Chrysalis International Corp., a President by Nextran, a President by Biolectron, Inc., a Founding Trustee by Biotechnology Council of New Jersey, Inc., and a Vice President & General Manager by Datex-Ohmeda, Inc. He also served on the board at Logical Therapeutics, Inc., Encorium Group, Inc., Acelerate, Inc., Agile Therapeutics, Inc. and Ventaira Pharmaceuticals, Inc.
He received his undergraduate degree from Lehigh University and an MBA from Rutgers State University of New Jersey.
Posizioni attive di Paul J. Schmitt
| Società | Posizione | Inizio |
|---|---|---|
Gel Med Sciences, Inc.
 Gel Med Sciences, Inc. Pharmaceuticals: MajorHealth Technology Gel Med Sciences, Inc. engages in the development of animal and human healthcare products. It offers ovugel that utilizes the company's gel drug delivery system to improve the timing of artificial inseminations in pig herds. The company was founded by Joseph S Duffey in 1999 and is headquartered in Wayne, PA. | Director/Board Member | 01/01/2000 |
The Wistar Institute
 The Wistar Institute BiotechnologyHealth Technology The Wistar Institute provides biomedical research services. It researches on diseases such as cancer, cardiovascular, autoimmune disorders and infectious diseases and develops vaccine. The company was founded in 1892 and is headquartered in Philadelphia, PA | Director/Board Member | - |
| JBS United Animal Health II LLC | Corporate Officer/Principal | 01/08/2013 |
Novitas Capital III LP
 Novitas Capital III LP Investment ManagersFinance Novitas Capital III LP seeks investment opportunities in companies located in the Mid-Atlantic region with a primary focus on Pennsylvania (US). The fund targets companies operating in the fields of technology and life science. It acts as a lead and co-lead investor for start-up and early stage capital requirements. Its initial investment size ranges from $0.1 to $2 million and invests up to $6 million over the lifetime of a portfolio investment. | Corporate Officer/Principal | - |
Penn State Research Foundation
 Penn State Research Foundation Miscellaneous Commercial ServicesCommercial Services Penn State Research Foundation provides scientific research services aimed at improving human conditions. The non-profit company is based in University Park, PA. | Corporate Officer/Principal | - |
Bellrock Intelligence, Inc.
 Bellrock Intelligence, Inc. Information Technology ServicesTechnology Services Bellrock Intelligence, Inc. operates as a healthcare information technology company. The firm offers business information management services, advanced analytics capabilities, and security and integration. The company was founded by Robert P. Rittereiser in 2007 and is headquartered in Wayne, PA. | Director/Board Member | - |
Precedenti posizioni note di Paul J. Schmitt
| Società | Posizione | Fine |
|---|---|---|
Novitas Capital Management LLC
 Novitas Capital Management LLC Investment ManagersFinance Novitas Capital Management (Novitas Capital) is a venture capital firm founded in 1997. The firm is headquartered in Wayne, Pennsylvania. | Private Equity Investor | 01/08/2018 |
Encorium Group, Inc.
 Encorium Group, Inc. Miscellaneous Commercial ServicesCommercial Services Encorium Group, Inc. is a clinical research organization which is engaged in the design and management of complex clinical trials for the pharmaceutical and biotechnology industries. It offers on a global basis broad range of clinical research and development services supporting Phase I through Phase IV clinical trials. The company's services include study protocol design, clinical trials management, global data management services, biostatistics, medical and regulatory affairs, quality assurance and compliance and medical report writing. The Encorium offers therapeutic areas such as vaccines, oncology, CNS/psychiatry, cardiovascular, dermatology, rheumatology, respiratory disorders and renal and urinary disorders. The company was founded on August 1, 1998 and is headquartered in Wayne, Pennsylvania. | Director/Board Member | 16/07/2008 |
Chrysalis International Corp.
 Chrysalis International Corp. Pharmaceuticals: MajorHealth Technology Chrysalis International Corp. provides drug development services to the pharmaceutical and biotechnology industries. Its services include transgenic discovery research, preclinical development and clinical capabilities. The company was founded in 1988 and is headquartered in Raritan, NJ. | Chief Executive Officer | 31/12/1998 |
| ░░░░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | - |
Formazione di Paul J. Schmitt
| Rutgers State University of New Jersey | Masters Business Admin |
| Lehigh University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| AGILE THERAPEUTICS, INC. | Health Technology |
| TETRALOGIC PHARMACEUTICALS CORPORATION | Health Technology |
| Aziende private | 18 |
|---|---|
Chrysalis International Corp.
Chrysalis International Corp. Pharmaceuticals: MajorHealth Technology Chrysalis International Corp. provides drug development services to the pharmaceutical and biotechnology industries. Its services include transgenic discovery research, preclinical development and clinical capabilities. The company was founded in 1988 and is headquartered in Raritan, NJ. | Health Technology |
Novitas Capital III LP
Novitas Capital III LP Investment ManagersFinance Novitas Capital III LP seeks investment opportunities in companies located in the Mid-Atlantic region with a primary focus on Pennsylvania (US). The fund targets companies operating in the fields of technology and life science. It acts as a lead and co-lead investor for start-up and early stage capital requirements. Its initial investment size ranges from $0.1 to $2 million and invests up to $6 million over the lifetime of a portfolio investment. | Finance |
Gel Med Sciences, Inc.
Gel Med Sciences, Inc. Pharmaceuticals: MajorHealth Technology Gel Med Sciences, Inc. engages in the development of animal and human healthcare products. It offers ovugel that utilizes the company's gel drug delivery system to improve the timing of artificial inseminations in pig herds. The company was founded by Joseph S Duffey in 1999 and is headquartered in Wayne, PA. | Health Technology |
Acelerate, Inc.
 Acelerate, Inc. BiotechnologyHealth Technology Acelerate, Inc. provides systems cell biology solutions. It address the problems of efficacy and toxicity with the cellular systems biology approach. The company was founded in 2004 and is headquartered in Pittsburgh, PA. | Health Technology |
Ventaira Pharmaceuticals, Inc.
 Ventaira Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ventaira Pharmaceuticals Inc. develops aerosol devices. It offers inhaled drugs, including fentanyl for the treatment of breakthrough pain and salmeterol/flucticasone for asthma. The company was founded in April 2000 and is headquartered in Columbus, OH. | Health Technology |
Amorcyte, Inc.
 Amorcyte, Inc. Miscellaneous Commercial ServicesCommercial Services Amorcyte, Inc. provides cell therapy product development services. It focuses on developing cell therapeutics for cardiovascular disease. The company was founded by Andrew L. Pecora in 2004 and is headquartered in Allendale, NJ. | Commercial Services |
Cernostics, Inc.
 Cernostics, Inc. Medical SpecialtiesHealth Technology Cernostics, Inc. develops and commercializes cancer diagnostic tests. Its technology is based on a systems approach to evaluating tissues via anatomic pathology and simultaneously evaluates immune, stromal, stem cell and tumor biomarkers on a single slide while preserving tissue structure. The company was founded in 2008 by Michel Nederlof and Rebecca Critchley-Thorne and is headquartered in Pittsburgh, PA. | Health Technology |
Nextran
 Nextran Medical SpecialtiesHealth Technology Part of Baxter International, Inc., Nextran is an American company that develops and commercializes organ transplantation technologies. The private company is based in NJ. Nextran was acquired by Baxter Healthcare Corp. from DNX Corp. on September 27, 1995 for $18 million. | Health Technology |
Biolectron, Inc.
 Biolectron, Inc. Medical SpecialtiesHealth Technology Biolectron, Inc. manufactures and markets instruments used in the re-attachment of soft tissue bone. The company is headquartered in Las Vegas, NV. | Health Technology |
Novitas Capital Management LLC
Novitas Capital Management LLC Investment ManagersFinance Novitas Capital Management (Novitas Capital) is a venture capital firm founded in 1997. The firm is headquartered in Wayne, Pennsylvania. | Finance |
The Wistar Institute
The Wistar Institute BiotechnologyHealth Technology The Wistar Institute provides biomedical research services. It researches on diseases such as cancer, cardiovascular, autoimmune disorders and infectious diseases and develops vaccine. The company was founded in 1892 and is headquartered in Philadelphia, PA | Health Technology |
Encorium Group, Inc.
Encorium Group, Inc. Miscellaneous Commercial ServicesCommercial Services Encorium Group, Inc. is a clinical research organization which is engaged in the design and management of complex clinical trials for the pharmaceutical and biotechnology industries. It offers on a global basis broad range of clinical research and development services supporting Phase I through Phase IV clinical trials. The company's services include study protocol design, clinical trials management, global data management services, biostatistics, medical and regulatory affairs, quality assurance and compliance and medical report writing. The Encorium offers therapeutic areas such as vaccines, oncology, CNS/psychiatry, cardiovascular, dermatology, rheumatology, respiratory disorders and renal and urinary disorders. The company was founded on August 1, 1998 and is headquartered in Wayne, Pennsylvania. | Commercial Services |
Logical Therapeutics, Inc.
 Logical Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Logical Therapeutics, Inc. develops products that treat diseases associated with inflammation. It provides a platform of bio-activated prodrugs for the chronic treatment of arthritis. Its bio-activated NSAID prodrugs are chemical entities that are designed to reduce the incidence of GI ulcers and improve GI tolerability in patients who require chronic NSAID treatment. The company was founded by Carolyn E. Green in 2005 and is headquartered in Waltham, MA. | Health Technology |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Commercial Services |
Datex-Ohmeda, Inc.
 Datex-Ohmeda, Inc. Industrial ConglomeratesProducer Manufacturing Part of General Electric Co., Datex-Ohmeda, Inc. develops and manufactures medical equipment. The private company is based in Madison, WI. | Producer Manufacturing |
Penn State Research Foundation
Penn State Research Foundation Miscellaneous Commercial ServicesCommercial Services Penn State Research Foundation provides scientific research services aimed at improving human conditions. The non-profit company is based in University Park, PA. | Commercial Services |
| JBS United Animal Health II LLC | |
Bellrock Intelligence, Inc.
Bellrock Intelligence, Inc. Information Technology ServicesTechnology Services Bellrock Intelligence, Inc. operates as a healthcare information technology company. The firm offers business information management services, advanced analytics capabilities, and security and integration. The company was founded by Robert P. Rittereiser in 2007 and is headquartered in Wayne, PA. | Technology Services |
- Borsa valori
- Insiders
- Paul J. Schmitt
